E
ASXC

Ergoteles’s Asensus Surgical, Inc. ASXC Stock Holding History

Ergoteles’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-219,715
Closed -$76.3K – 1865
2022
Q4 		$76.3K Sell
219,715
-748,272
-77% -$304K ﹤0.01% 1252
2022
Q3 		$434K Sell
967,987
-75,876
-7% -$39.6K 0.02% 811
2022
Q2 		$416K Buy
1,043,863
+985,763
+1,697% +$440K 0.01% 924
2022
Q1 		$36K Buy
+58,100
New +$44.8K ﹤0.01% 1153

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ergoteles's ASXC Position: Q1 2023 in Review

Ergoteles sold out of Asensus Surgical, Inc. (ASXC) in Q1 2023, closing a stake of 219,715 shares — an estimated $76.3K sold.

Ergoteles first reported a position in ASXC in Q1 2022 and held it in 4 quarters. The position peaked at $434K in Q3 2022. 79 funds tracked by Wall St. Rank hold ASXC as of Q1 2023.

  • Ergoteles reported no remaining Asensus Surgical, Inc. position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 219,715 Asensus Surgical, Inc. shares in Q1 2023, an estimated $76.3K.
  • Ergoteles first reported a position in Asensus Surgical, Inc. in Q1 2022 and held it in 4 quarters.
  • Ergoteles's Asensus Surgical, Inc. position peaked at $434K in Q3 2022.
  • 79 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.